NagasakoEM, JohnsonRW, GriffinDR, DworkinRH. Rash severity in herpes zoster: Correlates and relationship to postherpetic neuralgia. J Am Acad Dermatol, 2002; 46,6:834.
4.
JungBF, JohnsonRW, GriffinDR, DworkinRH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurol, 2004; 62,9:1545–1551.
5.
ThyregodHGet al.Natural history of pain following herpes zoster. Pain, 2007; 128:148–156.
6.
JohnsonRW, BouhassiraDet al.The impact of herpes zoster and post-herpetic neuralgia on quality of life. BMC Med, 2010; 8:37.
7.
WeinkeT, EdteAet al.Impact of herpes zoster and post-herpetic neuralgia on patients' quality of life: A patient-reported outcomes survey. Z Gesundh Wiss, 2010; 18,4:367–374.
8.
DroletM, BrissonM, SchmaderKEet al.The impact of herpes zoster and postherpetic neuralgia on health related quality of life: A prospective study. CMAJ, 2010; 182,16:1731–1736.
ThakurR, PhilipAG. Treating herpes zoster and post herpetic neuralgia: An evidence based approach. J Fam Pract, 2012; 61,S9:S9–S15.
11.
DworkinRH, SchmaderKE. Epidemiology and natural history of herpes zoster and postherpetic neuralgia. WatsonCPN. GershonAA. Herpes Zoster and Postherpetic Neuralgia, 2nd. New York: Elsevier Press, 2001; 39–64.
12.
TyringS, BarbarashRA, NahlikJEet al.Famciclovir for the treatment of acute herpes zoster: Effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Ann Intern Med, 1995; 123:89–96.
13.
AttalN, CruccuGet al.EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol, 2010; 17:1113–1123.
14.
DubinskyRM, KabbaniH, El-ChamiZ, BoutwellC, AliH. An evidence based report of the quality standards subcommitee of the American Academy of Neurology. Neurol, 2004; 63:959–965.
